Challenges of Cell, Gene, CAR-T and the Personalized Medicine Supply Chain (WS26)

The attendee will be able to:

1. Define personalized medicine.
2. Describe the process of developing supply chains for personalized medicine.
3. List two (2) major challenges or strategies employed for delivering a robust personalized medicine supply chain.
4. Compare and contrast the logistics requirements of standard cold chain products versus cell and gene therapy products.
5. List at least two (2) concerns in the handling of cell and gene therapy clinical materials.
6. Describe the appropriate classification and labeling of cell and gene therapy products to ensure compliant transportation.